Collectively, these disparate findings on the association between mitochondrial haplotype, APOE genotype, and risk of AD emphasize the importance of a precision medicine approach that considers mitochondrial genetic variance in combination with nuclear genetics. This evidence concerns the gene APOE and Alzheimer disease.